In a new episode of What’s Your Why, James Smith, co-founder and Chief Revenue Officer of 4C Labs, a Canadian Cannabis company operating in Guernsey and the UK, sits down with Hannah and Mike to share what brought him to the sector.
After studying Political Science at Bishops University, James had a number of careers before cannabis, including as a chef, filmmaker and in real estate sales and development.
He made the decision to leave his stable career in real estate after seeing the benefits that medical cannabis was having for his nephew —and the wider family— after he was diagnosed with a neurological disorder.
4C Labs was founded over six years ago with the intent of creating a high quality and well priced medical cannabis supply chain for the UK and other international markets.
Focused on patients and their satisfaction, James and the team employ a very rigorous and empirical method to sourcing and pricing products that they believe will exceed patient expectations.
James is also the Chair of the Cannabis Industry Council Prescription Cannabis Sub committee and spends much of his time promoting cannabis as medicine and advocating for greater awareness and increased points of access in the UK.
Despite the challenges he has faced working in the sector, James maintains a positive perspective on the future growth of the industry and the general awareness of cannabis as a medicine that can improve people's quality of life.
A quick thank you to our sponsors:
This episode What’s Your Why podcast is sponsored by Curaleaf Laboratories.
Curaleaf Laboratories are the UK-leading experts in the manufacture and distribution of EU-GMP medical cannabis as part of Curaleaf International, the biggest cannabis company in the world.
In 2019, Rokshaw joined the Curaleaf International group and because of this, in August 2020, became the first manufacturer of full spectrum medical cannabis in the UK. We aligned with the Curaleaf mission, to provide wider access and unlock the potential of medical cannabis to those who need it.
With over a decade of experience in unlicensed medicines (Specials), Curaleaf have invested heavily in our state-of-the-art UK manufacturing facility, making us perfectly positioned with our international vertically integrated supply chain to deliver cannabis-based medicinal products (CBPM’s) of the highest quality for specialists to prescribe to their patients.
Curaleaf’s wealth of medical cannabis experience, combined with a network of supply and distribution partnerships throughout Europe and the UK, mean that it is uniquely positioned to meet the rapidly growing demand for cost-effective, consistent, premium quality medical cannabis products in the UK.
Find out more at curaleaflaboratories.co.uk
4C Labs was founded over six years ago with the intent of creating a high quality and well priced medical cannabis supply chain for the UK and other international markets. Focused on patients and their satisfaction, James and the team employ a very rigorous and empirical method to sourcing and pricing products that they believe will exceed patient expectations.
James is also the Chair of the Cannabis Industry Council Prescription Cannabis Sub committee and spends much of his time promoting cannabis as medicine and advocating for greater awareness and increased points of access in the UK.
Hosted on Acast. See acast.com/privacy for more information.